Guardant Health Valuation
| GH Stock | USD 106.15 6.90 6.10% |
At this time, the firm appears to be fairly valued. Guardant Health retains a regular Real Value of $105.93 per share. The prevalent price of the firm is $106.15. Our model calculates the value of Guardant Health from evaluating the firm fundamentals such as return on equity of -45.84, and Return On Asset of -0.2 as well as inspecting its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Guardant Health's valuation include:
Price Book 55.6696 | Enterprise Value | Enterprise Value Ebitda (5.40) | Price Sales 15.2744 | Enterprise Value Revenue 17.0942 |
Fairly Valued
Today
Please note that Guardant Health's price fluctuation is very steady at this time. Calculation of the real value of Guardant Health is based on 3 months time horizon. Increasing Guardant Health's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Guardant Health is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Guardant Stock. However, Guardant Health's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 106.15 | Real 105.93 | Target 125.24 | Hype 106.15 | Naive 102.45 |
The intrinsic value of Guardant Health's stock can be calculated using various methods such as discounted cash flow or dividend analysis. That value may differ from its market price, which is determined by factors such as investor sentiment, market trends, headlines, and other external factors that may influence Guardant Health's stock price.
Estimating the potential upside or downside of Guardant Health helps investors to forecast how Guardant stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Guardant Health more accurately as focusing exclusively on Guardant Health's fundamentals will not take into account other important factors: When choosing an evaluation method for Guardant Health, ensure it is appropriate for the firm given its current financial situation and market classification. If more than one evaluation category is relevant, we suggest using all methods to arrive at a better estimate.
Guardant Health Cash |
|
Guardant Revenue by Product
Guardant Health Total Value Analysis
Guardant Health is currently forecasted to have takeover value of 15.67 B with market capitalization of 13.79 B, debt of 1.34 B, and cash on hands of 853.69 M. Please note that takeover value may be misleading and is a subject to accounting mistakes. We encourage investors to methodically examine all of the Guardant Health fundamentals before making investment evaluation based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
15.67 B | 13.79 B | 1.34 B | 853.69 M |
Guardant Health Investor Information
About 97.0% of the company shares are owned by institutional investors. The company recorded a loss per share of 3.03. Guardant Health had not issued any dividends in recent years. Guardant Health may be sliding down financialy. It has an above-average probability of going through some form of financial hardship next quarter.Guardant Health Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Guardant Health has an asset utilization ratio of 49.74 percent. This signifies that the Company is making $0.5 for each dollar of assets. An increasing asset utilization means that Guardant Health is more efficient with each dollar of assets it utilizes for everyday operations.Guardant Health Profitability Analysis
Considering the key profitability indicators obtained from Guardant Health's historical financial statements, Guardant Health may not be well positioned to generate adequate gross income at this time. It has a very high probability of underperforming in March. Profitability indicators assess Guardant Health's ability to earn profits and add value for shareholders.Net Loss | First Reported 2016-12-31 | Previous Quarter -99.9 M | Current Value -92.7 M | Quarterly Volatility 54.1 M |
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Gross Profit Margin | 0.43 | 0.55 |
|
|
For Guardant Health profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Guardant Health to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Guardant Health utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Guardant Health's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Guardant Health over time as well as its relative position and ranking within its peers.
Guardant Health Earnings per Share Projection vs Actual
By analyzing Guardant Health's earnings estimates, investors can diagnose different trends across Guardant Health's analyst sentiment over time as well as compare current EPS estimates against different timeframes. Please be aware that the consensus of earnings estimates for Guardant Health is based on EPS before non-recurring items and includes expenses related to employee stock options.Guardant Health Ownership Allocation
Guardant Health has a total of 129.87 Million outstanding shares. The majority of Guardant Health outstanding shares are owned by outside corporations. These institutional investors are usually referred to as non-private investors looking to purchase positions in Guardant Health to benefit from reduced commissions. Consequently, third-party entities are subject to a different set of regulations than regular investors in Guardant Health. Please pay attention to any change in the institutional holdings of Guardant Health as this could imply that something significant has changed or is about to change at the company. Also note that almost one million nine hundred fourty-eight thousand one hundred sixteen invesors are currently shorting Guardant Health expressing very little confidence in its future performance.Guardant Health Profitability Analysis
The company generated the yearly revenue of 739.02 M. Annual Net Loss to common stockholders was (436.37 M) with gross profit of 575.46 M.About Guardant Health Valuation
An absolute valuation paradigm, as applied to Guardant Stock, attempts to find the value of Guardant Health based on its fundamental and basic technical indicators. By analyzing Guardant Health's financials, quarterly and monthly indicators, and their related drivers, such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of Guardant Health's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Guardant Health. We calculate exposure to Guardant Health's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Guardant Health's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 516.6 M | 542.4 M | |
| Pretax Profit Margin | (0.53) | (0.56) | |
| Operating Profit Margin | (0.54) | (0.57) | |
| Net Loss | (0.53) | (0.56) | |
| Gross Profit Margin | 0.55 | 0.43 |
Guardant Health Current Valuation Indicators
Valuation refers to the process of determining the present value of Guardant Health and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Guardant we look at many different elements of the entity such as Guardant's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Guardant Health, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Guardant Health's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Guardant Health's worth.Complementary Tools for Guardant Stock analysis
When running Guardant Health's price analysis, check to measure Guardant Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Guardant Health is operating at the current time. Most of Guardant Health's value examination focuses on studying past and present price action to predict the probability of Guardant Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Guardant Health's price. Additionally, you may evaluate how the addition of Guardant Health to your portfolios can decrease your overall portfolio volatility.
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated |